1. Home
  2. PR vs NBIX Comparison

PR vs NBIX Comparison

Compare PR & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Permian Resources Corporation

PR

Permian Resources Corporation

N/A

Current Price

$23.16

Market Cap

18.5B

Sector

Energy

ML Signal

N/A

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

N/A

Current Price

$142.31

Market Cap

15.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PR
NBIX
Founded
2015
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.5B
15.5B
IPO Year
2016
1996

Fundamental Metrics

Financial Performance
Metric
PR
NBIX
Price
$23.16
$142.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
23
29
Target Price
$27.19
★ $207.29
AVG Volume (30 Days)
★ 8.8M
1.2M
Earning Date
11-04-2026
10-27-2026
Dividend Yield
★ 2.80%
N/A
EPS Growth
N/A
★ 41.95
EPS
0.99
★ 3.30
Revenue
★ $5,065,211,000.00
$161,626,000.00
Revenue This Year
$32.64
$36.45
Revenue Next Year
$2.56
$16.61
P/E Ratio
★ $23.07
$42.80
Revenue Growth
1.29
★ 977.51
52 Week Low
$11.92
$122.14
52 Week High
$24.65
$186.12

Technical Indicators

Market Signals
Indicator
PR
NBIX
Relative Strength Index (RSI) 58.85 41.40
Support Level $22.61 $125.18
Resistance Level $24.37 $142.82
Average True Range (ATR) 0.55 3.38
MACD 0.12 0.64
Stochastic Oscillator 91.57 55.45

Price Performance

Historical Comparison
PR
NBIX

About PR Permian Resources Corporation

Permian Resources Corp is an independent oil and natural gas company focused on generating outsized returns to stakeholders through the responsible acquisition, optimization, and development of oil and liquids-rich natural gas assets. The Company's assets and operations are concentrated in the core of the Permian Basin, and its properties consist of large, contiguous acreage blocks located in West Texas and New Mexico.

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

Share on Social Networks: